Seer (SEER) Total Operating Expense: $81.42 Mil (TTM As of Mar. 2026)


SEER Seer Inc SEER
53 GF Score
Price $1.62
GF Value $2.19
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Seer Total Operating Expense?

Seer SEER -0.61% 53 Total Operating Expense is $81.42 Mil as of Mar. 2026. GuruFocus rates SEER with a GF Score™ of 53/100 and a GF Value™ of $2.19 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Seer's Total Operating Expense for the three months ended in Mar. 2026 was $18.15 Mil. Seer's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $81.42 Mil.

Seer Total Operating Expense Related Terms

Seer Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Seer's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seer Total Operating Expense Chart

Seer Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 74.66 103.52 110.49 106.93 86.00

Seer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.73 22.52 21.30 19.44 18.15
SEER
53GF Score
Seer Inc SEER
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seer Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $81.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $81.42 Mil mean?
Seer (SEER) has a Total Operating Expense of $81.42 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Seer and its competitors.
Is Seer's Total Operating Expense too high?
Seer's current Total Operating Expense is $81.42 Mil. Overall, Seer has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seer's Total Operating Expense compare to CSBR and RLYB?
Seer's Total Operating Expense of $81.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Seer and its competitors. Seer's current Total Operating Expense is $81.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seer stock overvalued right now?
Based on GuruFocus' analysis, Seer (SEER) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.19, compared to a current price of $1.62 — trading 26% below its estimated fair value. The current Total Operating Expense is $81.42 Mil. Seer's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Seer (SEER), the current Total Operating Expense is $81.42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seer (SEER) Overvalued in 2026?

Based on GuruFocus' analysis, Seer stock appears to be undervalued. The current stock price of $1.62 is trading 26% below its estimated GF Value™ of $2.19. GuruFocus considers Seer to be Modestly Undervalued.

Key valuation signals for SEER:

  • Total Operating Expense: $81.42 Mil
  • GF Value™: $2.19 vs. price of $1.62 (26% below fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the SEER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seer Business Description

Address 3800 Bridge Parkway, Suite 102, Redwood City, CA, USA, 94065
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
53GF Score

Get the complete analysis for SEER

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.62
Price
$2.19
GF Value